Timothy H. Holtz

6 ta ish

Centers for Disease Control and Prevention

1. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

   Shama D. Ahuja, David Ashkin, Monika Avendano +70

   Sharh maqolaOAOchiq kirish20129 iqtibos

   ABIABI:AkademIndex/2026.other.027993

2. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

   Dennis Falzon, Neel R. Gandhi, Giovanni Battista Migliori +11

   Sharh maqolaOAOchiq kirish20124 iqtibos

   ABIABI:AkademIndex/2026.other.027990

3. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

   Mayara Lisboa Bastos, Hamidah Hussain, Karin Weyer +82

   Sharh maqolaOAOchiq kirish20144 iqtibos

   ABIABI:AkademIndex/2026.other.034193

4. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.034216

5. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

   Dennis Falzon, E. Jaramillo, Holger J. Schünemann +43

   MaqolaOAOchiq kirish20113 iqtibos

   ABIABI:AkademIndex/2026.other.169932

6. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

   Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi +16

   Sharh maqolaOAOchiq kirish20122 iqtibos

   ABIABI:AkademIndex/2026.other.027989